Evaluating treatment effects reliably : Although principles are well known, they are ignored too often

Por Landray, Martin J, Whitlock, Gary
Publicado em 2002

Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: cross-sectional study

Por Landray, Martin J, Lehman, Richard, Arnold, Ian
Publicado em 2000

Neprilysin inhibition in chronic kidney disease

Por Judge, Parminder, Haynes, Richard, Landray, Martin J., Baigent, Colin
Publicado no Nephrol Dial Transplant (2015)

An overview of antithrombotic therapy

Por Blann, Andrew D, Landray, Martin J, Lip, Gregory Y H
Publicado em 2002

Estimated Glomerular Filtration Rate and the Risk of Major Vascular Events and All-Cause Mortality: A Meta-Analysis

Por Mafham, Marion, Emberson, Jonathan, Landray, Martin J., Wen, Chi-Pang, Baigent, Colin
Publicado em 2011

Enhancing clinical evidence by proactively building quality into clinical trials

Por Meeker-O’Connell, Ann, Glessner, Coleen, Behm, Mark, Mulinde, Jean, Roach, Nancy, Sweeney, Fergus, Tenaerts, Pamela, Landray, Martin J
Publicado no Clin Trials (2016)

Serum Free Light Chains and the Risk of ESRD and Death in CKD

Por Haynes, Richard, Hutchison, Colin A., Emberson, Jonathan, Dasgupta, Tanaji, Wheeler, David C., Townend, John N., Landray, Martin J., Cockwell, Paul
Publicado em 2011

Use of Causal Diagrams to Inform the Design and Interpretation of Observational Studies: An Example from the Study of Heart and Renal Protection (SHARP)

Por Staplin, Natalie, Herrington, William G., Judge, Parminder K., Reith, Christina A., Haynes, Richard, Landray, Martin J., Baigent, Colin, Emberson, Jonathan
Publicado no Clin J Am Soc Nephrol (2017)

Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD

Por Morton, Rachael L., Schlackow, Iryna, Staplin, Natalie, Gray, Alastair, Cass, Alan, Haynes, Richard, Emberson, Jonathan, Herrington, William, Landray, Martin J., Baigent, Colin, Mihaylova, Borislava
Publicado no Am J Kidney Dis (2016)

Evaluating the Contribution of the Cause of Kidney Disease to Prognosis in CKD: Results From the Study of Heart and Renal Protection (SHARP)

Por Haynes, Richard, Staplin, Natalie, Emberson, Jonathan, G. Herrington, William, Tomson, Charles, Agodoa, Lawrence, Tesar, Vladimir, Levin, Adeera, Lewis, David, Reith, Christina, Baigent, Colin, Landray, Martin J.
Publicado em 2014

What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?

Por Kent, Seamus, Schlackow, Iryna, Lozano-Kühne, Jingky, Reith, Christina, Emberson, Jonathan, Haynes, Richard, Gray, Alastair, Cass, Alan, Baigent, Colin, Landray, Martin J, Herrington, William, Mihaylova, Borislava
Publicado no BMC Nephrol (2015)

Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)

Por Mihaylova, Borislava, Schlackow, Iryna, Herrington, William, Lozano-Kühne, Jingky, Kent, Seamus, Emberson, Jonathan, Reith, Christina, Haynes, Richard, Cass, Alan, Craig, Jonathan, Gray, Alastair, Collins, Rory, Landray, Martin J., Baigent, Colin
Publicado no Am J Kidney Dis (2016)

The Effect of Lowering LDL Cholesterol on Vascular Access Patency: Post Hoc Analysis of the Study of Heart and Renal Protection

Por Herrington, William, Emberson, Jonathan, Staplin, Natalie, Blackwell, Lisa, Fellström, Bengt, Walker, Robert, Levin, Adeera, Hooi, Lai Seong, Massy, Ziad A., Tesar, Vladimir, Reith, Christina, Haynes, Richard, Baigent, Colin, Landray, Martin J.
Publicado em 2014

Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney Disease

Por Herrington, William, Staplin, Natalie, Judge, Parminder K., Mafham, Marion, Emberson, Jonathan, Haynes, Richard, Wheeler, David C., Walker, Robert, Tomson, Charlie, Agodoa, Larry, Wiecek, Andrzej, Lewington, Sarah, Reith, Christina A., Landray, Martin J., Baigent, Colin
Publicado no Hypertension (2017)

Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)

Por Staplin, Natalie, Haynes, Richard, Herrington, William G., Reith, Christina, Cass, Alan, Fellström, Bengt, Jiang, Lixin, Kasiske, Bertram L., Krane, Vera, Levin, Adeera, Walker, Robert, Wanner, Christoph, Wheeler, David C., Landray, Martin J., Baigent, Colin, Emberson, Jonathan
Publicado no Am J Kidney Dis (2016)

Prediction of ESRD and Death Among People With CKD: The Chronic Renal Impairment in Birmingham (CRIB) Prospective Cohort Study

Por Landray, Martin J., Emberson, Jonathan R., Blackwell, Lisa, Dasgupta, Tanaji, Zakeri, Rosita, Morgan, Matthew D., Ferro, Charlie J., Vickery, Susan, Ayrton, Puja, Nair, Devaki, Dalton, R. Neil, Lamb, Edmund J., Baigent, Colin, Townend, Jonathan N., Wheeler, David C.
Publicado em 2010

Effects of Lowering LDL Cholesterol on Progression of Kidney Disease

Por Haynes, Richard, Lewis, David, Emberson, Jonathan, Reith, Christina, Agodoa, Lawrence, Cass, Alan, Craig, Jonathan C., de Zeeuw, Dick, Feldt-Rasmussen, Bo, Fellström, Bengt, Levin, Adeera, Wheeler, David C., Walker, Rob, Herrington, William G., Baigent, Colin, Landray, Martin J., Baigent, Colin, Landray, Martin J., Reith, Christina, Emberson, Jonathan, Wheeler, David C., Tomson, Charles, Wanner, Christoph, Krane, Vera, Cass, Alan, Craig, Jonathan, Neal, Bruce, Jiang, Lixin, Hooi, Lai Seong, Levin, Adeera, Agodoa, Lawrence, Gaziano, Mike, Kasiske, Bertram, Walker, Rob, Massy, Ziad A., Feldt-Rasmussen, Bo, Krairittichai, Udom, Ophascharoensuk, Vuddidhej, Fellström, Bengt, Holdaas, Hallvard, Tesar, Vladimir, Wiecek, Andrzej, Grobbee, Diederick, de Zeeuw, Dick, Grönhagen-Riska, Carola, Dasgupta, Tanaji, Lewis, David, Herrington, Will, Mafham, Marion, Majoni, William, Wallendszus, Karl, Grimm, Richard, Pedersen, Terje, Tobert, Jonathan, Armitage, Jane, Baxter, Alex, Bray, Christopher, Chen, Yiping, Chen, Zhengming, Hill, Michael, Knott, Carol, Parish, Sarah, Simpson, David, Sleight, Peter, Young, Alan, Collins, Rory
Publicado em 2014

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stoppi...

Por Haynes, Richard, Jiang, Lixin, Hopewell, Jemma C, Li, Jing, Chen, Fang, Parish, Sarah, Landray, Martin J., Collins, Rory, Armitage, Jane, Collins, R., Armitage, J., Baigent, C., Chen, Z., Landray, M., Chen, Y., Jiang, L., Pedersen, T., Landray, M., Bowman, L., Chen, F., Hill, M., Haynes, R., Knott, C., Rahimi, K., Tobert, J., Sleight, P., Simpson, D., Parish, S., Baxter, A., Lay, M., Bray, C., Wincott, E., Leijenhorst, G., Skattebol, A., Moen, G., Mitchel, Y., Kuznetsova, O., MacMahon, S., Kjekshus, J., Hill, C., Lam, T.H., Sandercock, P., Peto, R., Hopewell, J.C.
Publicado em 2013

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controll...

Por Baigent, Colin, Landray, Martin J, Reith, Christina, Emberson, Jonathan, Wheeler, David C, Tomson, Charles, Wanner, Christoph, Krane, Vera, Cass, Alan, Craig, Jonathan, Neal, Bruce, Jiang, Lixin, Hooi, Lai Seong, Levin, Adeera, Agodoa, Lawrence, Gaziano, Mike, Kasiske, Bertram, Walker, Robert, Massy, Ziad A, Feldt-Rasmussen, Bo, Krairittichai, Udom, Ophascharoensuk, Vuddidhej, Fellström, Bengt, Holdaas, Hallvard, Tesar, Vladimir, Wiecek, Andrzej, Grobbee, Diederick, de Zeeuw, Dick, Grönhagen-Riska, Carola, Dasgupta, Tanaji, Lewis, David, Herrington, William, Mafham, Marion, Majoni, William, Wallendszus, Karl, Grimm, Richard, Pedersen, Terje, Tobert, Jonathan, Armitage, Jane, Baxter, Alex, Bray, Christopher, Chen, Yiping, Chen, Zhengming, Hill, Michael, Knott, Carol, Parish, Sarah, Simpson, David, Sleight, Peter, Young, Alan, Collins, Rory
Publicado em 2011